HK Stock MarketDetailed Quotes

01772 GANFENGLITHIUM

Watchlist
  • 22.450
  • +0.700+3.22%
Market Closed Apr 26 16:08 CST
45.29BMarket Cap8.24P/E (TTM)

GANFENGLITHIUM Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Turnover
-20.69%32.81B
-6.99%25.68B
26.47%18.11B
75.91%9.44B
274.63%41.37B
291.45%27.61B
255.80%14.32B
233.91%5.37B
101.20%11.04B
81.19%7.05B
Operating income
-20.69%32.81B
-6.99%25.68B
26.47%18.11B
75.91%9.44B
274.63%41.37B
291.45%27.61B
255.80%14.32B
233.91%5.37B
101.20%11.04B
81.19%7.05B
Cost of sales
-34.26%-28.2B
----
-146.90%-13.98B
----
-214.18%-21.01B
----
-116.17%-5.66B
----
-54.52%-6.69B
----
Operating expenses
-34.26%-28.2B
-74.24%-21.21B
-146.90%-13.98B
-230.59%-5.92B
-214.18%-21.01B
-167.74%-12.17B
-116.17%-5.66B
-61.64%-1.79B
-54.52%-6.69B
-43.85%-4.55B
Gross profit
-77.37%4.61B
-71.03%4.47B
-52.30%4.13B
-1.48%3.52B
367.39%20.36B
515.75%15.44B
516.08%8.66B
615.33%3.58B
275.08%4.36B
242.32%2.51B
Selling expenses
-51.19%-177.44M
-46.13%-102.14M
-69.27%-68.73M
-158.47%-29.92M
-90.45%-117.36M
-84.60%-69.89M
-69.74%-40.6M
8.23%-11.57M
-27.82%-61.62M
13.85%-37.86M
Administrative expenses
-16.78%-2.34B
-28.31%-654.98M
-16.51%-1.06B
31.23%-150.72M
-137.96%-2B
-79.88%-510.48M
-332.53%-912.27M
-577.20%-219.16M
-155.94%-840.34M
-185.67%-283.79M
Research and development expenses
----
1.13%-941.62M
----
-84.99%-391.93M
----
-373.80%-952.43M
----
-477.87%-211.86M
----
-157.01%-201.02M
Profit from asset sales
----
-65.30%1.39M
----
---13.59K
----
1,776.76%3.99M
----
----
----
81.66%-238.15K
Revaluation surplus
----
24.76%650.52M
----
-67.56%153.83M
----
-47.53%521.44M
----
187.17%474.21M
----
10,256.09%993.76M
-Changes in the fair value of other assets
----
24.76%650.52M
----
-67.56%153.83M
----
-47.53%521.44M
----
187.17%474.21M
----
10,256.09%993.76M
Impairment and provision
----
-2,471.08%-1.01B
----
-1,222,994.39%-1.2B
----
-221.98%-39.29M
----
-22.79%-98.32K
----
89.07%-12.2M
-Other impairment is provision
----
-2,471.08%-1.01B
----
-1,222,994.39%-1.2B
----
-221.98%-39.29M
----
-22.79%-98.32K
----
89.07%-12.2M
Operating interest expense
----
----
-75.95%-342.58M
----
----
----
-36.24%-194.71M
----
0.39%-264.86M
----
Special items of operating profit
2.80%1.05B
47.26%4.31B
318.50%1.36B
29.45%605.69M
-59.32%1.02B
5,744.98%2.93B
-197.39%-620.54M
3,340.25%467.89M
319.46%2.52B
-55.11%50.05M
Operating profit
-83.66%3.15B
-61.01%6.67B
-41.78%4.01B
-38.31%2.49B
237.56%19.27B
475.71%17.11B
313.87%6.89B
591.53%4.04B
409.87%5.71B
511.38%2.97B
Financing cost
-92.55%-784.31M
-477.51%-379.61M
----
-251.25%-139.16M
---407.33M
167.67%100.56M
----
23.43%-39.62M
----
-103.41%-148.59M
Share of profits of associates
-44.83%923.76M
----
0.30%620.29M
----
2,401.34%1.67B
----
1,582.72%618.43M
----
364.55%66.94M
----
Share of profit from joint venture company
-10.47%2.01B
----
78.07%1.62B
----
42,985.18%2.24B
----
1,536.91%909.21M
----
-115.61%-5.22M
----
Special items of earning before tax
----
78.19%44.6M
----
-100.66%-211.19K
----
451.86%25.03M
----
98,424.68%31.87M
----
-305.28%-7.11M
Earning before tax
-76.76%5.29B
-63.24%6.34B
-25.74%6.25B
-41.64%2.35B
294.71%22.78B
512.00%17.23B
413.83%8.42B
657.30%4.03B
411.65%5.77B
584.73%2.82B
Tax
70.52%-683.47M
79.70%-455.97M
64.57%-377.64M
59.91%-189.78M
-549.34%-2.32B
-718.81%-2.25B
-502.34%-1.07B
-1,115.48%-473.42M
-460.54%-357M
-256.58%-274.36M
After-tax profit from continuing operations
-77.46%4.61B
-60.77%5.88B
-20.11%5.87B
-39.21%2.16B
277.92%20.46B
489.68%14.99B
403.11%7.35B
621.15%3.56B
408.73%5.41B
660.26%2.54B
Earning after tax
-77.46%4.61B
-60.77%5.88B
-20.11%5.87B
-39.21%2.16B
277.92%20.46B
489.68%14.99B
403.11%7.35B
621.15%3.56B
408.73%5.41B
660.26%2.54B
Minority profit
-765.08%-371.56M
-167.78%-130.35M
-103.55%-3.43M
-765.72%-232.63M
-122.83%-42.95M
179.56%192.32M
110.08%96.74M
98.93%34.94M
383.36%188.14M
1,699.52%68.79M
Profit attributable to shareholders
-75.70%4.98B
-59.38%6.01B
-19.00%5.88B
-32.01%2.4B
292.35%20.5B
498.31%14.79B
412.65%7.25B
640.41%3.53B
409.69%5.23B
648.24%2.47B
Basic earnings per share
-75.74%2.47
-59.46%2.98
-18.89%2.92
-32.00%1.19
281.27%10.18
315.25%7.35
386.49%3.6
386.11%1.75
237.97%2.67
608.00%1.77
Diluted earnings per share
-75.71%2.47
-59.35%2.98
-18.89%2.92
-32.00%1.19
282.33%10.17
314.12%7.33
386.49%3.6
386.11%1.75
236.71%2.66
608.00%1.77
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
Audit Opinions
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Turnover -20.69%32.81B-6.99%25.68B26.47%18.11B75.91%9.44B274.63%41.37B291.45%27.61B255.80%14.32B233.91%5.37B101.20%11.04B81.19%7.05B
Operating income -20.69%32.81B-6.99%25.68B26.47%18.11B75.91%9.44B274.63%41.37B291.45%27.61B255.80%14.32B233.91%5.37B101.20%11.04B81.19%7.05B
Cost of sales -34.26%-28.2B-----146.90%-13.98B-----214.18%-21.01B-----116.17%-5.66B-----54.52%-6.69B----
Operating expenses -34.26%-28.2B-74.24%-21.21B-146.90%-13.98B-230.59%-5.92B-214.18%-21.01B-167.74%-12.17B-116.17%-5.66B-61.64%-1.79B-54.52%-6.69B-43.85%-4.55B
Gross profit -77.37%4.61B-71.03%4.47B-52.30%4.13B-1.48%3.52B367.39%20.36B515.75%15.44B516.08%8.66B615.33%3.58B275.08%4.36B242.32%2.51B
Selling expenses -51.19%-177.44M-46.13%-102.14M-69.27%-68.73M-158.47%-29.92M-90.45%-117.36M-84.60%-69.89M-69.74%-40.6M8.23%-11.57M-27.82%-61.62M13.85%-37.86M
Administrative expenses -16.78%-2.34B-28.31%-654.98M-16.51%-1.06B31.23%-150.72M-137.96%-2B-79.88%-510.48M-332.53%-912.27M-577.20%-219.16M-155.94%-840.34M-185.67%-283.79M
Research and development expenses ----1.13%-941.62M-----84.99%-391.93M-----373.80%-952.43M-----477.87%-211.86M-----157.01%-201.02M
Profit from asset sales -----65.30%1.39M-------13.59K----1,776.76%3.99M------------81.66%-238.15K
Revaluation surplus ----24.76%650.52M-----67.56%153.83M-----47.53%521.44M----187.17%474.21M----10,256.09%993.76M
-Changes in the fair value of other assets ----24.76%650.52M-----67.56%153.83M-----47.53%521.44M----187.17%474.21M----10,256.09%993.76M
Impairment and provision -----2,471.08%-1.01B-----1,222,994.39%-1.2B-----221.98%-39.29M-----22.79%-98.32K----89.07%-12.2M
-Other impairment is provision -----2,471.08%-1.01B-----1,222,994.39%-1.2B-----221.98%-39.29M-----22.79%-98.32K----89.07%-12.2M
Operating interest expense ---------75.95%-342.58M-------------36.24%-194.71M----0.39%-264.86M----
Special items of operating profit 2.80%1.05B47.26%4.31B318.50%1.36B29.45%605.69M-59.32%1.02B5,744.98%2.93B-197.39%-620.54M3,340.25%467.89M319.46%2.52B-55.11%50.05M
Operating profit -83.66%3.15B-61.01%6.67B-41.78%4.01B-38.31%2.49B237.56%19.27B475.71%17.11B313.87%6.89B591.53%4.04B409.87%5.71B511.38%2.97B
Financing cost -92.55%-784.31M-477.51%-379.61M-----251.25%-139.16M---407.33M167.67%100.56M----23.43%-39.62M-----103.41%-148.59M
Share of profits of associates -44.83%923.76M----0.30%620.29M----2,401.34%1.67B----1,582.72%618.43M----364.55%66.94M----
Share of profit from joint venture company -10.47%2.01B----78.07%1.62B----42,985.18%2.24B----1,536.91%909.21M-----115.61%-5.22M----
Special items of earning before tax ----78.19%44.6M-----100.66%-211.19K----451.86%25.03M----98,424.68%31.87M-----305.28%-7.11M
Earning before tax -76.76%5.29B-63.24%6.34B-25.74%6.25B-41.64%2.35B294.71%22.78B512.00%17.23B413.83%8.42B657.30%4.03B411.65%5.77B584.73%2.82B
Tax 70.52%-683.47M79.70%-455.97M64.57%-377.64M59.91%-189.78M-549.34%-2.32B-718.81%-2.25B-502.34%-1.07B-1,115.48%-473.42M-460.54%-357M-256.58%-274.36M
After-tax profit from continuing operations -77.46%4.61B-60.77%5.88B-20.11%5.87B-39.21%2.16B277.92%20.46B489.68%14.99B403.11%7.35B621.15%3.56B408.73%5.41B660.26%2.54B
Earning after tax -77.46%4.61B-60.77%5.88B-20.11%5.87B-39.21%2.16B277.92%20.46B489.68%14.99B403.11%7.35B621.15%3.56B408.73%5.41B660.26%2.54B
Minority profit -765.08%-371.56M-167.78%-130.35M-103.55%-3.43M-765.72%-232.63M-122.83%-42.95M179.56%192.32M110.08%96.74M98.93%34.94M383.36%188.14M1,699.52%68.79M
Profit attributable to shareholders -75.70%4.98B-59.38%6.01B-19.00%5.88B-32.01%2.4B292.35%20.5B498.31%14.79B412.65%7.25B640.41%3.53B409.69%5.23B648.24%2.47B
Basic earnings per share -75.74%2.47-59.46%2.98-18.89%2.92-32.00%1.19281.27%10.18315.25%7.35386.49%3.6386.11%1.75237.97%2.67608.00%1.77
Diluted earnings per share -75.71%2.47-59.35%2.98-18.89%2.92-32.00%1.19282.33%10.17314.12%7.33386.49%3.6386.11%1.75236.71%2.66608.00%1.77
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)
Audit Opinions Unqualified Opinion------Unqualified Opinion------Unqualified Opinion--
Auditor Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg